The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials
Open accessAbstract
Nature has been instrumental as a source for therapeutics. Despite the fact that we live in an oceanic planet, a number of technical factors have historically hampered the evolution of a marine-based chamanic medicine. With the implementation of scuba diving tools and the development of sophisticated instruments for the isolation and elucidation of structures of natural products from marine organisms, major advances have been made in the discovery of marine derived therapeutics. The availability of ARA-C, a nucleoside analog that is a basic component in the treatment of acute myeloid leukemia, and its fluorinated analog Gemcitabine, an important therapeutic tool in the treatment of pancreatic cancer and in non small cell lung cancer, is a solid proof and validation of the potential of this approach. As a result of our discovery and developmental program, three innovative compounds with novel mechanisms of action: ET-743, AplidinR and Kahalalide F, have been shown to display a positive therapeutic index and activity in resistant solid tumors that supports the ongoing clinical phase III/II trials. ET-743 represents the first active agent against sarcomas developed in the past 25 years and has demonstrated a therapeutic potential in pretreated ovarian cancer. Several chemical entities are under advanced preclinical testing and additional candidates for clinical development are emerging, including compounds hitting a specific target. Moreover, the development of a given marine candidate implies the collaboration of an interdisciplinary team special focused on supply, formulation, pharmacogenetics and preclinical toxicology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BERGMANN, W., & BURKE, D. C. (1955) · The Journal of Organic Chemistry · doi:10.1021/jo01128a007 · Cited by 194
Cited by
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Bhalerao, S., & Kadam, P. (2010) · International Journal of Ayurveda Research · doi:10.4103/0974-7788.59946 · Cited by 798
Marine natural products as anticancer drugs
Simmons, T. L., Andrianasolo, E., McPhail, K., Flatt, P., & Gerwick, W. H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.333.4.2 · Cited by 597
Phycobiliproteins from cyanobacteria: Chemistry and biotechnological applications
Pagels, F., Guedes, A. C., Amaro, H. M., Kijjoa, A., & Vasconcelos, V. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.010 · Cited by 426
Bioactive Peptides and Depsipeptides with Anticancer Potential: Sources from Marine Animals
Suarez-Jimenez, G.-M., Burgos-Hernandez, A., & Ezquerra-Brauer, J.-M. (2012) · Marine Drugs · doi:10.3390/md10050963 · Cited by 275
Metadata
- Authors
- Jimeno, J., Faircloth, G., Sousa-Faro, J. F., Scheuer, P., & Rinehart, K.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2004-02-25
- Volume
- 2
- Issue
- 1
- Pages
- 14-29
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W2119197678
- Cited by
- 179
- References
- 1
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials. https://app.cochat.ai/papers/10.3390/md201014
- The paper
- Jimeno, J., Faircloth, G., Sousa-Faro, J. F., Scheuer, P., & Rinehart, K. (2004). New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials. Marine Drugs. https://doi.org/10.3390/md201014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.